Study of the anti-exudative activity of dry extract from Prunus Domestica fruits

Abstract

Topicality. Previous experimental studies of the pharmacological properties of extracts from Prunus domestica fruits revealed the most therapeutically active extract with fibers by laxative and hepatoprotective activities. The hepatoprotective activity of the dry extract from Prunus domestica fruits containing fibers is probably due to the presence of polyphenolic components in the chemical composition of the extract. Based on the analysis of the literature data for polyphenolic compounds, anti-exudative properties are characteristic; therefore, it was reasonable to study the effect of the investigated extract on the cyclooxygenase and lipoxygenase routes of the inflammatory reaction development. Aim. To investigate experimentally the effect of dry extract from Prunus domestica fruits containing fibers on the development of the anti-exudative phase of inflammation. Results and discussion. The pretreatment of the animals with extract from Prunus domestica fruits moderately suppressed the development of zymosan-induced edema in all studied periods. Indicators of anti-exudative activity of the studied extract (29.65 %) were lower than activity of reference drug quercetin (36.6 %) and were at the level of indicators of anti-flogogenic manifestations of the reference drug Silybor (29.5 %). The moderate anti-exudative activity of the investigated extract suggests that it suppresses the formation of leukotrienes in the early stages of the inflammatory reaction development (0.5 hours), and prostaglandins – after 3 hours. Conclusions. Analysis of the experimental data showed a slight anti-cyclo-oxygenase and anti-lipooxygenase activity of the dry extract from Prunus domestica fruits containing fibers. The investigated extract was lower in its ability to inhibit the anti-cyclooxygenase and anti-lipooxygenase pathways of the development of the exudative phase of inflammation than the reference drug quercetin. The moderate anti-inflammatory effect of this extract is probably due to the presence of polyphenolic compounds in its chemical composition.

Authors and Affiliations

I. V. Senyuk, Bashar Jabbar Ali Al-Sahlanee

Keywords

Related Articles

Investigation of the mebhydroline by chromatographic methods

Topicality. Mebhydroline napadisylate (diazolin) – 3-methyl-9-benzyl-1,2,3,4-tetrahydrocarbolyn naphthalene-1,5- disulfonate – is a first-generation antihistamine, used for the prevention and treatment of seasonal and al...

The study of microbiological purity of ointment “Fitolan” during storage

Topicality. Mastopathy is a benign disease of the mammary glands, and it belongs to a number of hormone-dependent pathologies. The danger of mastopathy is not only in that it significantly reduces the quality of life of...

Определение острой токсичности галеновых и новогаленовых фитосубстанций из листьев брусники обыкновенной

Актуальность. На этапе первичного токсико-фармакологического скрининга определения класса токсичности исследуемых фитосубстанций, которые имеют разный качественный и количественный состав, он является первым этапом докли...

Investigation of follicle stimulating effect of medical cosmetic remedies on the androgen alopecia model in rats

Topicality. Androgenic alopecia (AA) is a progressive baldness caused by the effect of androgens on the hair follicle (HF) that develops in people with genetic predisposition. One of the important approaches to AA therap...

Biopharmaceutical and microbiological studies of hard gelatin capsules with multicomponent herbal dry extract

Topicality. The statistical data indicate that surgical intervention is about 33.23 %. among the methods of genitourinary system treatment. Therefore, there is a problem to reduce their number by increasing the effective...

Download PDF file
  • EP ID EP660393
  • DOI 10.24959/ubphj.19.220
  • Views 72
  • Downloads 0

How To Cite

I. V. Senyuk, Bashar Jabbar Ali Al-Sahlanee (2019). Study of the anti-exudative activity of dry extract from Prunus Domestica fruits. Український біофармацевтичний журнал, 59(2), 55-59. https://europub.co.uk/articles/-A-660393